网站大量收购独家精品文档,联系QQ:2885784924

Non-small cell lung cancer patients Detection of serum protein markers.doc

Non-small cell lung cancer patients Detection of serum protein markers.doc

  1. 1、本文档共12页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Non-small cell lung cancer patients Detection of serum protein markers

 PAGE \* MERGEFORMAT 12 Non-small cell lung cancer patients Detection of serum protein markers Of: Yang Yang Zhao Song Jianjun Liu Dong Tang Yan Lei Zhu [Abstract] Objective To detect non-small cell lung cancer (NSCLC serum protein, specific protein markers selected to build for the early diagnosis of NSCLC serum protein fingerprint model. Methods surface-enhanced laser desorption ionization time of flight mass spectrometry (SELDI TOF MS) serum samples of 235 cases detected by mass spectrometry of proteins, combined with bioinformatics methods (support vector machine) to analyze the data. The results were screened 3 z (m / z) in 6628,9191 and 11412 protein marker, building NSCLC early diagnosis. United 3 potential protein markers, the leave-one-out cross validation, the distinction between NSCLC and normal healthy controls with a sensitivity of 98%, a specificity of 96%. blind test shows that the model sensitivity of diagnosis of NSCLC was 96.56%, a specificity of 94.79%. Conclusion SELDI TOF MS combined with support vector machine model of NSCLC serum protein pattern of early diagnosis of NSCLC, a high sensitivity and specificity of the new method is worthy of further research and application. [Keywords:] non-small cell lung cancer, diagnosis, support vector machines, biological markers Lung cancer is the world’s highest death rates in tumors, all cancer deaths accounted for about 25% (1). Non-small cell lung cancer (NSCLC accounts for about 80% incidence of lung cancer (2). Early diagnosis and reasonable treatment to improve long-term survival and prognosis of NSCLC patients is important (3). NSCLC stage mainly depends on the clinical diagnosis of chest X ray camera, CT, cell puncture study, bronchoscopy, etc., although most cases can be diagnosed, but not early detection and prognosis of missed timing of treatment effects (4). proteomics for the early diagnosis of NSCLC provides new ideas and technology platform (5). In this study, surface-enhanc

文档评论(0)

jiupshaieuk12 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档